Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06624904 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Losartan and Social Processing

StatusCompleted
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Site details revised
  2. Primary and study completion dates: Feb 25, 2025 to Oct 1, 2025v3 Show 4 more changesShow less
    • Trial status: Completed to Recruiting
    • Enrollment target: 58 to 68
    • Study description revised
    • Site details revised
  3. Trial status: Recruiting to Completed
    • Primary and study completion dates changed from estimate of Dec 2024 to Feb 25, 2025
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study explores the effects of single-dose losartan (50mg) versus placebo on social processing in healthy volunteers.
Trial Details
NCT Number NCT06624904
Lead Sponsor University of Oxford
Collaborators: National Institute for Health Research, United Kingdom
Conditions
(from sponsor)		 Social Cognition
Enrollment 68 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov